{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:22:24Z","timestamp":1791595344616,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>IL-31, which is a member of the IL-6 family of cytokines, is produced mainly by activated CD4<jats:sup>+<\/jats:sup> T cells, in particular activated Th2 cells, suggesting a contribution to development of type-2 immune responses. IL-31 was reported to be increased in specimens from patients with atopic dermatitis, and IL-31-transgenic mice develop atopic dermatitis-like skin inflammation, which is involved in the pathogenesis of atopic dermatitis. However, the role of IL-31 in development of contact dermatitis\/contact hypersensitivity (CHS), which is mediated by hapten-specific T cells, including Th2 cells, is not fully understood. Therefore, we investigated this using IL-31-deficient (<jats:italic>Il31<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup>) mice, which we newly generated. We demonstrated that the mice showed normal migration and maturation of skin dendritic cells and induction of hapten-specific T cells in the sensitization phase of FITC-induced CHS, and normal induction of local inflammation in the elicitation phase of FITC- and DNFB-induced CHS. On the other hand, those mice showed reduced scratching frequency and duration during FITC- and\/or DNFB-induced CHS. Our findings suggest that IL-31 is responsible for pruritus, but not induction of local skin inflammation, during CHS induced by FITC and DNFB.<\/jats:p>","DOI":"10.1038\/s41598-018-25094-4","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T09:55:06Z","timestamp":1524477306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity"],"prefix":"10.1038","volume":"8","author":[{"given":"Ayako","family":"Takamori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2797-6420","authenticated-orcid":false,"given":"Aya","family":"Nambu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenshiro","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Arae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuko","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Kitaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Nakae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"25094_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ni1084","volume":"5","author":"SR Dillon","year":"2004","unstructured":"Dillon, S. R. et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5, 752\u2013760, https:\/\/doi.org\/10.1038\/ni1084 (2004).","journal-title":"Nat Immunol"},{"key":"25094_CR2","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1182\/blood-2008-09-179416","volume":"113","author":"T Ishii","year":"2009","unstructured":"Ishii, T. et al. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. Blood 113, 5942\u20135950, https:\/\/doi.org\/10.1182\/blood-2008-09-179416 (2009).","journal-title":"Blood"},{"key":"25094_CR3","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.4049\/jimmunol.0900712","volume":"184","author":"F Niyonsaba","year":"2010","unstructured":"Niyonsaba, F. et al. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J Immunol 184, 3526\u20133534, https:\/\/doi.org\/10.4049\/jimmunol.0900712 (2010).","journal-title":"J Immunol"},{"key":"25094_CR4","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.1365-2133.2011.10487.x","volume":"165","author":"C Cornelissen","year":"2011","unstructured":"Cornelissen, C. et al. Ultraviolet B radiation and reactive oxygen species modulate interleukin-31 expression in T lymphocytes, monocytes and dendritic cells. Br J Dermatol 165, 966\u2013975, https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10487.x (2011).","journal-title":"Br J Dermatol"},{"key":"25094_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-014-0423-y","volume":"14","author":"A Rabenhorst","year":"2014","unstructured":"Rabenhorst, A. & Hartmann, K. Interleukin-31: a novel diagnostic marker of allergic diseases. Curr Allergy Asthma Rep 14, 423, https:\/\/doi.org\/10.1007\/s11882-014-0423-y (2014).","journal-title":"Curr Allergy Asthma Rep"},{"key":"25094_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.006","volume":"26","author":"HM Hermanns","year":"2015","unstructured":"Hermanns, H. M. & Oncostatin, M. and interleukin-31: Cytokines, receptors, signal transduction and physiology. Cytokine Growth Factor Rev 26, 545\u2013558, https:\/\/doi.org\/10.1016\/j.cytogfr.2015.07.006 (2015).","journal-title":"Cytokine Growth Factor Rev"},{"key":"25094_CR7","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.4049\/jimmunol.1101044","volume":"188","author":"J Horejs-Hoeck","year":"2012","unstructured":"Horejs-Hoeck, J. et al. Dendritic cells activated by IFN-gamma\/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment. J Immunol 188, 5319\u20135326, https:\/\/doi.org\/10.4049\/jimmunol.1101044 (2012).","journal-title":"J Immunol"},{"key":"25094_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/gut.2006.118679","volume":"56","author":"J Dambacher","year":"2007","unstructured":"Dambacher, J. et al. Interleukin 31 mediates MAP kinase and STAT1\/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Gut 56, 1257\u20131265, https:\/\/doi.org\/10.1136\/gut.2006.118679 (2007).","journal-title":"Gut"},{"key":"25094_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1365-2567.2007.02668.x","volume":"122","author":"WK Ip","year":"2007","unstructured":"Ip, W. K. et al. Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response. Immunology 122, 532\u2013541, https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02668.x (2007).","journal-title":"Immunology"},{"key":"25094_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1398-9995.2009.02255.x","volume":"65","author":"S Kasraie","year":"2010","unstructured":"Kasraie, S., Niebuhr, M. & Werfel, T. Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins. Allergy 65, 712\u2013721, https:\/\/doi.org\/10.1111\/j.1398-9995.2009.02255.x (2010).","journal-title":"Allergy"},{"key":"25094_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/2045-7022-2-13","volume":"2","author":"R Baumann","year":"2012","unstructured":"Baumann, R. et al. The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms. Clin Transl Allergy 2, 13, https:\/\/doi.org\/10.1186\/2045-7022-2-13 (2012).","journal-title":"Clin Transl Allergy"},{"key":"25094_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1398-9995.2007.01566.x","volume":"63","author":"Z Lei","year":"2008","unstructured":"Lei, Z. et al. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy 63, 327\u2013332, https:\/\/doi.org\/10.1111\/j.1398-9995.2007.01566.x (2008).","journal-title":"Allergy"},{"key":"25094_CR13","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.4049\/jimmunol.0902769","volume":"185","author":"J Bilsborough","year":"2010","unstructured":"Bilsborough, J., Mudri, S., Chadwick, E., Harder, B. & Dillon, S. R. IL-31 receptor (IL-31RA) knockout mice exhibit elevated responsiveness to oncostatin M. J Immunol 185, 6023\u20136030, https:\/\/doi.org\/10.4049\/jimmunol.0902769 (2010).","journal-title":"J Immunol"},{"key":"25094_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","volume":"117","author":"E Sonkoly","year":"2006","unstructured":"Sonkoly, E. et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117, 411\u2013417, https:\/\/doi.org\/10.1016\/j.jaci.2005.10.033 (2006).","journal-title":"J Allergy Clin Immunol"},{"key":"25094_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jaci.2008.05.047","volume":"122","author":"U Raap","year":"2008","unstructured":"Raap, U. et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 122, 421\u2013423, https:\/\/doi.org\/10.1016\/j.jaci.2008.05.047 (2008).","journal-title":"J Allergy Clin Immunol"},{"key":"25094_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jaci.2006.07.015","volume":"118","author":"MM Neis","year":"2006","unstructured":"Neis, M. M. et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 118, 930\u2013937, https:\/\/doi.org\/10.1016\/j.jaci.2006.07.015 (2006).","journal-title":"J Allergy Clin Immunol"},{"key":"25094_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejphar.2005.04.040","volume":"516","author":"A Takaoka","year":"2005","unstructured":"Takaoka, A. et al. Expression of IL-31 gene transcripts in NC\/Nga mice with atopic dermatitis. Eur J Pharmacol 516, 180\u2013181, https:\/\/doi.org\/10.1016\/j.ejphar.2005.04.040 (2005).","journal-title":"Eur J Pharmacol"},{"key":"25094_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1600-0625.2008.00766.x","volume":"18","author":"O Grimstad","year":"2009","unstructured":"Grimstad, O. et al. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC\/Nga mice: a model of atopic dermatitis. Exp Dermatol 18, 35\u201343, https:\/\/doi.org\/10.1111\/j.1600-0625.2008.00766.x (2009).","journal-title":"Exp Dermatol"},{"key":"25094_CR19","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1111\/bph.12823","volume":"171","author":"K Kasutani","year":"2014","unstructured":"Kasutani, K. et al. Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. Br J Pharmacol 171, 5049\u20135058, https:\/\/doi.org\/10.1111\/bph.12823 (2014).","journal-title":"Br J Pharmacol"},{"key":"25094_CR20","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1606490","volume":"376","author":"T Ruzicka","year":"2017","unstructured":"Ruzicka, T. et al. Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis. N Engl J Med 376, 826\u2013835, https:\/\/doi.org\/10.1056\/NEJMoa1606490 (2017).","journal-title":"N Engl J Med"},{"key":"25094_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nri3150","volume":"12","author":"DH Kaplan","year":"2012","unstructured":"Kaplan, D. H., Igyarto, B. Z. & Gaspari, A. A. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 12, 114\u2013124, https:\/\/doi.org\/10.1038\/nri3150 (2012).","journal-title":"Nat Rev Immunol"},{"key":"25094_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2332\/allergolint.R-07-160","volume":"57","author":"K Oboki","year":"2008","unstructured":"Oboki, K., Ohno, T., Saito, H. & Nakae, S. Th17 and allergy. Allergol Int 57, 121\u2013134, https:\/\/doi.org\/10.2332\/allergolint.R-07-160 (2008).","journal-title":"Allergol Int"},{"key":"25094_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.20061791","volume":"204","author":"JG Perrigoue","year":"2007","unstructured":"Perrigoue, J. G. et al. IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. J Exp Med 204, 481\u2013487, https:\/\/doi.org\/10.1084\/jem.20061791 (2007).","journal-title":"J Exp Med"},{"key":"25094_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1046\/j.1365-3083.1997.d01-402.x","volume":"45","author":"B Weigmann","year":"1997","unstructured":"Weigmann, B. et al. Diminished contact hypersensitivity response in IL-4 deficient mice at a late phase of the elicitation reaction. Scand J Immunol 45, 308\u2013314 (1997).","journal-title":"Scand J Immunol"},{"key":"25094_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1046\/j.1523-1747.1999.00550.x","volume":"112","author":"C Traidl","year":"1999","unstructured":"Traidl, C., Jugert, F., Krieg, T., Merk, H. & Hunzelmann, N. Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol 112, 476\u2013482, https:\/\/doi.org\/10.1046\/j.1523-1747.1999.00550.x (1999).","journal-title":"J Invest Dermatol"},{"key":"25094_CR26","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1084\/jem.191.6.995","volume":"191","author":"H Yokozeki","year":"2000","unstructured":"Yokozeki, H. et al. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 191, 995\u20131004 (2000).","journal-title":"J Exp Med"},{"key":"25094_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","volume":"133","author":"F Cevikbas","year":"2014","unstructured":"Cevikbas, F. et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. J Allergy Clin Immunol 133, 448\u2013460, https:\/\/doi.org\/10.1016\/j.jaci.2013.10.048 (2014).","journal-title":"J Allergy Clin Immunol"},{"key":"25094_CR28","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.4049\/jimmunol.176.7.4102","volume":"176","author":"H Suto","year":"2006","unstructured":"Suto, H. et al. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 176, 4102\u20134112 (2006).","journal-title":"J Immunol"},{"key":"25094_CR29","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1073\/pnas.1003059107","volume":"107","author":"K Oboki","year":"2010","unstructured":"Oboki, K. et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 107, 18581\u201318586, https:\/\/doi.org\/10.1073\/pnas.1003059107 (2010).","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25094-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25094-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25094-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:47:11Z","timestamp":1671598031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25094-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25094"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25094-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"20 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6639"}}